About
Pasithea Therapeutics is a biotechnology company focused on discovering and developing treatments for central nervous system disorders and RASopathies, including Neurofibromatosis type 1, Amyotrophic Lateral Sclerosis, Multiple Sclerosis, and schizophrenia.
Explore pasithea therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.